Valentine Karen 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed Apr 29, 2020
Insider Transaction Report
Form 4
Valentine Karen
See Remarks
Transactions
- Sale
Common Stock
2020-04-27$40.13/sh−400$16,052→ 0 total - Exercise/Conversion
Common Stock
2020-04-27$11.50/sh+400$4,600→ 400 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-04-27−400→ 113,985 totalExercise: $11.50Exp: 2028-07-18→ Common Stock (400 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $40.03 to $40.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on July 19, 2018. The shares underlying the option are scheduled to vest in equal quarterly installments through July 16, 2022.